Cronos Group Inc. to Speak at 38th Annual ROTH Conference
Digest more
Net revenue of $44.5 million in Q4 2025 increased by $14.2 million from Q4 2024. The increase was primarily due to higher cannabis flower sales in Israel and other countries, which carry no excise taxes, and higher cannabis flower and extract sales in the ...
Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do $24.8 million in sales in Q3, and to lose money -- $0.01 ...
Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement Administration (DEA) announced it wouldn't hold a public meeting ...
Hosted on MSN
Cronos just bought Europe’s top cannabis producer — is this the catalyst investors have waited 5 years for?
For years, North American cannabis investors have endured a brutal hangover. Cronos Group (NASDAQ:CRON), once a darling of the 2018-2019 marijuana mania, watched its share price collapse more than 95% from all-time highs as Canada’s adult-use rollout ...
Cronos Group Inc. (NASDAQ:CRON) is among the 11 Best Pot Stocks to Buy According to Hedge Funds. On February 24, TD Securities initiated coverage of Cronos Group Inc. (NASDAQ:CRON) with a Buy rating and C$4.
For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a gloomier note, its headline net loss deepened by 55% to ...
TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company (“GrowCo”). GrowCo is a leading cannabis cultivation ...
Cronos Group’s smaller size and production capacity would be less of an issue if its market cap were not the third largest of firms listed in Figure 5. This lofty valuation makes it even harder for Cronos Group’s operations to justify the expectations baked into its stock price.
Cronos Group Inc. (NASDAQ:CRON) is one of the Low Risk Penny Stocks to Buy Now. On February 26, Cronos Group Inc. (NASDAQ:CRON) reported its fiscal Q4 2025 earnings. The company posted $44.53 million in quarterly revenue,
Shares of Cronos Group Inc. CRON slipped 1.14% to $2.60 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.02% to 22,
Analysts covering Cronos Group are centering their views around a CA$4.50 price target and a CA$4.235 fair value estimate that remains unchanged, putting the current debate squarely on how the stock might trade relative to this range.